Recent updates from Raymond James Financial (RJF) indicate a mixed financial milieu. The firm's stock price evaluations have been observed to be changed by prominent financial institutions and analysts like Morgan Stanley, Goldman Sachs and Barclays. Analysts from UBS and TD Cowen have reiterated hold ratings on the stock with revised target prices. While investment banking and brokerage activities have been robust, the stock is facing pressure due to a revenue miss in their Q4 report. Similarly, there is strong institutional backing with large shareholders like J. Safra Sarasin and Allspring Global Investments increasing their investments. Regardless of reported momentum weakness and recent management turnover, Raymond James has managed impressive asset growth and revenue expansion, largely driven by organic growth and strategic acquisitions such as the recently completed Greensledge transaction. The company's commitment to technological advancement is seen in acquired AI firm Altruist which could potentially reshape its wealth strategy. Despite inconsistencies in performance, there is consensus among some analysts that Raymond James presents a strong value proposition for long-term investors.
Raymond James Financial RJF News Analytics from Fri, 22 Aug 2025 07:00:00 GMT to Sat, 11 Apr 2026 12:00:26 GMT -
Rating 1
- Innovation -1
- Information 8
- Rumor -4
